Clinical significance of aspergillus isolation from respiratory samples in severe COPD patients. Usefulness of Ascioglu‘s criteria Source: Annual Congress 2008 - Biomarkers and antibiotic treatment of exacerbations of COPD Year: 2008
Using routine spirometry to obtain sputum samples in the respiratory clinic Source: Annual Congress 2011 - Update on monitoring airway diseases Year: 2011
IGRA testing correlation with clinical and laboratory parameters in patients with tuberculosis Source: Annual Congress 2011 - Risk assessment for tuberculosis Year: 2011
Positive predictive value of breathprint analysis for clinical remission of acute LRTI and for differentiation between AE-COPD and CAP Source: International Congress 2017 – How can microbiology and translational research help physicians? Year: 2017
The prognostic significance of different clinical, radiological and laboratory parameters in sarcoidosis Source: Eur Respir J 2003; 22: Suppl. 45, 46s Year: 2003
The clinical significance of plasma and urine lysophospholipids-producing enzymes in patients with sarcoidosis Source: Virtual Congress 2020 – Genetics and biomarkers for diagnosis and prognosis of granulomatous lung diseases Year: 2020
Comparison of sputum characteristics with clinical, laboratorial and functional variables in patients with stable COPD Source: Annual Congress 2010 - Colonisation and infection in COPD Year: 2010
Prognostic significance of chronic respiratory symptoms in individuals with normal spirometry Source: Eur Respir J, 55 (1) 1902226; 10.1183/13993003.02226-2019 Year: 2020
Prognostic significance of chronic respiratory symptoms in individuals with normal spirometry Source: Eur Respir J, 55 (1) 1902093; 10.1183/13993003.02093-2019 Year: 2020
Prognostic significance of chronic respiratory symptoms in individuals with normal spirometry Source: Eur Respir J, 54 (3) 1900734; 10.1183/13993003.00734-2019 Year: 2019
The diagnostic value of induced-sputum in patients with tuberculosis Source: Eur Respir J 2003; 22: Suppl. 45, 160s Year: 2003
Yield of examining repeated sputum specimens in diagnosis of pulmonary tuberculosis: how many sputum samples are adequate? Source: Eur Respir J 2004; 24: Suppl. 48, 33s Year: 2004
Interpretations of three sputum smear examinations at the first diagnosis in our hospital‘s tuberculosis patients Source: Annual Congress 2012 - Tuberculous and non-tuberculous mycobacterial infections: diagnostic tools Year: 2012
A cost-benefit analysis of the value of third sputum smear for the diagnosis of tuberculosis in India Source: Annual Congress 2009 - Socio-economic impact of tuberculosis Year: 2009
Bacteriologic picture of infection foci in lung resection specimens of smear-negative tuberculosis patients Source: Eur Respir J 2004; 24: Suppl. 48, 421s Year: 2004
Role of bronchial aspirate samples for the diagnosis of pulmonary tuberculosis in patients with negative smear and negative Xpert MTB/Rif in sputum Source: Virtual Congress 2020 – Diagnostic challenges in tuberculosis Year: 2020
BAL and microbiological surveillance of nosocomial pneumonia in ARDS patients Source: Eur Respir J 2006; 28: Suppl. 50, 786s Year: 2006
The clinical significances of bronchial anthracofibrosis in the patients with endobronchial tuberculosis Source: Eur Respir J 2004; 24: Suppl. 48, 202s Year: 2004
A study to assess the magnitude and reasons of initial default among sputum smear positive pulmonary tuberculosis patients Source: Annual Congress 2010 - Tuberculosis control Year: 2010
Comparison of diagnostic value and culmination period for bactec 960, Lowenstein-Jensen culture and mtd gen-probe in clinical specimens isolated from smear-negative TB patients Source: Annual Congress 2009 - Diagnostic advances in tuberculosis Year: 2009